The global small scale bioreactors market is estimated to Propelled...

The global small scale bioreactors market is estimated to Propelled by Growth in Biomanufacturing Industry

Сообщение 2023-12-20 12:40:55

2Кб

Small Scale Bioreactors Market Overview:
Small scale bioreactors are benchtop vessels used for culturing cells or microorganisms in biomanufacturing applications. They offer advantages like higher productivity, reduced turnaround time and flexibility for research activities in biopharmaceutical and biotech industries. Growing demand for biologics, recombinant proteins and stem cell therapies is driving the need for small scale bioreactors used in R&D and process development processes.

The global small scale bioreactors market is estimated to be valued at US$ 1508.86 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Growth in biomanufacturing industry has been a major trend propelling the small scale bioreactors market. Biomanufacturing refers to production of biopharmaceuticals, vaccines and therapeutics using living organisms like cells and microbes. It is witnessing increased adoption over conventional manufacturing for its ability to produce complex molecules with high precision. Expanding global biopharmaceutical industry has increased investments in R&D and process development which utilizes small scale bioreactors. Moreover, growing development of cell and gene therapies has also driven their demand for evaluation and optimization of manufacturing processes at a small scale using benchtop bioreactors. This rapid expansion of biomanufacturing sector is expected to significantly drive the small scale bioreactors market during the forecast period.

SWOT Analysis
Strength: Small scale bioreactors offer reduced capital investment as compared to large scale industrial bioreactors. They are suitable for research, development and process optimization activities.
Weakness: Limited production capacity and scalability. Small scale bioreactors are suitable only for R&D and pilot scale production.
Opportunity: Growing adoption in research activities of biopharmaceutical and biotechnology companies. Increasing investment in cell and gene therapy research also offers new opportunities.
Threats: Challenges in validating processes developed at small scale for large scale production. Intense competition from major bioreactor manufacturers.

Key Takeaways
The global Small Scale Bioreactors Market Demand is expected to witness high growth over the forecast period supported by increasing R&D investment of pharmaceutical companies. North America currently dominates the market due to presence of major players and strong biopharmaceutical industry in the region. The North America small scale bioreactors market is projected to reach US$ 638.63 Mn by 2030 growing at a CAGR of 10.4% during the forecast period.

Key players operating in the small scale bioreactors market are Merck KGaA, Danaher Corporation, Getinge AB, Sartorius AG, Thermo Fisher Scientific Inc., Lonza Group, Eppendorf AG, Miltenyi Biotec, Solaris Biotechnology Srl, Infors AG, Biosan, MicroDigital Co. Ltd., 2mag AG, MDX Biotechnik International GmbH, Esco Lifesciences Group, HiTec Zang GmbH, Hanil Scientific Inc., Adolf Kühner AG, Ori Biotech, Aglaris and AdvaBio.

Merck KGaA and Danaher Corporation hold a major share of the market. Major players are focusing on new product launches, collaborations and expansion in emerging markets to strengthen their position in the global market. For instance, in December 2020, Merck KGaA launched new small scale MidiBio High-Performance bioreactors and controllers for applications requiring 5-100L vessel volumes, expanding its bioreactors portfolio.

For more details on the report, Read- http://marketerefforts.weebly.com/home/small-scale-bioreactors-market-is-driven-by-increased-demand-for-monoclonal-antibodies